MDCalc

MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)

Quantifies end-stage liver disease for transplant planning.

We’ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. Click here to view.

Note: This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. The newer MELD Score is listed as “MELD Score”.

Dialysis at least twice in the past week

Result:

Please fill out required fields.
Advice

The MELD score helps to estimate prognosis for patients with end-stage liver disease, and is used to prioritize transplant recipients.